Sabinsa Successfully Protects its Curcumin C3 Reduct Technology

Sabinsa Corporation announced today that it has successfully concluded its Patent Infringement lawsuit against Aegle Bios, Inc.

July 10, 2017

1 Min Read
Sabinsa Successfully Protects its Curcumin C3 Reduct Technology

Sabinsa Corporation announced today that it has successfully concluded its Patent Infringement lawsuit against Aegle Bios, Inc.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like

Recommended

thumbnail
Ideation
Pets: 13 ingredients (not counting peanut butter) that are pretty good ideas for humans, tooPets: 13 ingredients (not counting peanut butter) that are pretty good ideas for humans, too
byBlake Ebersole
Sep 16, 2024
6 Min Read
thumbnail
Supplement Regulations
FDA official addresses kratom on Capitol HillFDA official addresses kratom on Capitol Hill
byJosh Long
Sep 13, 2024
4 Min Read
8 ways supplement companies leverage science to drive sales and consumer trust
Sponsored Content
8 ways supplement companies leverage science to drive sales and consumer trust – spotlight8 ways supplement companies leverage science to drive sales and consumer trust – spotlight
Sep 13, 2024
5 Min Read
thumbnail
Supplement Regulations
FDA’s Jones reiterated support for dietary supplement listing requirementFDA’s Jones reiterated support for dietary supplement listing requirement
byJosh Long
Sep 12, 2024
3 Min Read
Recent headlines